期刊文献+

DPD对ACS急诊PCI术神经内分泌因子及并发症的影响

Effect of Distal Protection Device on the Level of Neuroendocrine and Complications in Emergency Percutaneous Coronary Intervention in Acute Coronary Syndrome
下载PDF
导出
摘要 目的探讨急性冠脉综合征(ACS)患者急诊经皮冠状动脉成形术(PCI)中远端保护装置对神经内分泌因子水平的影响。方法回顾性分析在我院行急诊PCI的67例ACS患者,依据是否应用远端保护装置分为研究组(应用远端保护装置)32例和对照组(未应用远端保护装置)35例。在术前及术后第1、3、5、7天分别测定并比较血浆中内皮素(ET)、肾上腺素(E)、去甲肾上腺素(NE)、肾素活性(PRA)、醛固酮(ALD)和血管紧张素Ⅱ(AngⅡ)水平。随访1个月,比较两组的急性血栓形成、亚急性血栓形成及猝死率等并发症的差异。结果研究组患者各因子水平随时间延长而降低(P<0.05);对照组ET、E、NE无明显变化(P>0.05),而PRA、ALD、AngⅡ水平随时间延长而降低(P<0.05)。两组术前及术后1d的PRA、ALD、AngⅡ水平无差异(P>0.05),而从术后3d开始,研究组PRA、ALD、AngⅡ水平较对照组明显偏低(P<0.05)。随访1个月后,研究组的急性血栓形成、亚急性血栓形成及猝死率均明显低于对照组(P<0.05或P<0.01)。结论 ACS患者急诊PCI中使用远端保护装置能降低术后RAS系统水平,减少并发症发生。 Objective To analyze the clinical effect of Percusurge distal protection device(DPD) on the level of plasma neuroendocrine and complications in emergency pereutaneous coronary intervention(PCI) in acute coronary syndrome(ACS). Methods A total of 67 patients with ACS by emergency PCI in our hospital were collected to retrospective analyses and divided into two groups, research group(applieated Percusurge DPD, 32 patients) and control group(non-applicated Percusurge DPD, 35patients), according to whether Percusurge DPD was applieated. The plasma levels of endothelin(ET), ePinephrine(E), norepinephrine(NE), plasma renin activity(PRA), aldosterone(ALD) and angiotensin II ( Ang II ) were measured on the day of operation and on the 1st, 3rd, 5th and 7th day after operation, respectively. After 1 month follow-up, the incidence of complications, such as acute coronary stent thrombosis, sub-acute coronary stent thrombosis and sudden death, were compared between two groups. Results The plasma levels of all the neuroendocrine elements in research group were decreasing aecompanyed therapy duration (P 〈 0.05 ). The plasma levels of ET, E, NE in control group were no ehanging(P 〉 0.05), but PRA, ALD, Ang II in control group were decreasing accompanyed therapy duration ( P 〈 0.05 ). The plasma levels of PRA, ALD, Ang IX in research group at pre-operation and the 1st day after operation were no difference betweell two groups(P 〉 0.05). Compared to control group, the plasma levels of PRA, ALD, Ang II were rapidly decreased in research group from the 3rd day after the operation(P 〈 0.05). After 1 month follow-up, the incidence of complications in research group were obviously lower than in control group(P 〈 0.05 or P 〈 0.01). Conclusion In patients with ACS, the Pereusurge DPD could decrease the plasma levels of RAS system and the 'incidence of complications during emergency PCI.
作者 王明
机构地区 绍兴第二医院
出处 《中国现代医生》 2011年第31期27-29,共3页 China Modern Doctor
关键词 急性冠脉综合征 经皮冠状动脉介入术 远端保护装置 神经内分泌因子 Acute coronary syndrome Percutaneous coronary intervention Distal protection device Neuroendocrine
  • 相关文献

参考文献7

二级参考文献41

  • 1蒙碧波,吕传柱,蒋宜颖.经皮冠状动脉介入治疗急性冠脉综合征的进展[J].中华急诊医学杂志,2005,14(8):696-698. 被引量:5
  • 2Peter R.Thromb in acute coronary syndromes[J].Circulation,2000,101 (2):1619-1626.
  • 3Van Ommen V,Michels R,Heymen E,et al.Usefulness of the rescue PT catheter to remove fresh thrombus from coronary arteries and bypass grafts in acute myocardial infarction[J].Am J Cardiol,2001,88(4):306-308.
  • 4Yamada DM,Topol EJ.Microvascular embolization in acute coronary syndromes[J].Acut Cor Syn,2001,4:1217.
  • 5Rezkalla SH,Kloner RA.No-reflow phenomenon[J].Circulation,2002,105:656 -662.
  • 6Skyschally A,Erbel R,Heusch G.Coronary.Microembolization[J].Circulation,2003,67:279 -286.
  • 7Piana RN,Paik GY,Moscucci M.Incidence and treatment of no-reflow after percutaneous coronary intervention[J].Circulation,1994,89:2514-2518.
  • 8Saber RS,Edwards WD,Bailey KR.Coronary embolization after balloon angioplasty or thrombolytic therapy:an autopsy study of 32 cases[J].J Am Coll Cardiol,1993,22:1283-1288.
  • 9Kotani J,Nanto S,Mintz GS,et al.Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome[J].Circulation,2002,106 (13):1672-1677.
  • 10Baim DS,Wahr,George B,et al.Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts[J].Circulation,2002,105:r13-rl9.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部